Page 173 - Pagetit
P. 173

NEUROSCIENCE OF PSYCHOACTIVE SUBSTANCE USE AND DEPENDENCE




                   understanding the complex human processes of dependence through careful
                   application of complex genetic approaches.
                     The two main approaches to estimate genetic and environmental
                   components of phenotypic variance are twin and adoption studies. Twin
                   studies strongly indicate the presence of genetic risk factors for multiple
                   aspects of smoking and alcohol dependence, including initiation,
                   continuation, amount consumed and cessation. Moreover a plethora of
                   studies indicate considerable commonality between tobacco and alcohol
                   dependence, making the identification of both common and substance-
                   unique genetic influences crucial and challenging. In addition to estimating
                   genetic liability, these studies provide further information about
                   environmental contributions, identifying that which is shared (i.e. that which
                   both twins have in common and which contributes to their similarity) and
                   that which is non-shared (contributing to the relative dissimilarity) (Heath,
                   Madden & Martin, 1998; Vanyukov & Tarter, 2000; Jacob et al., 2001).


                   Table 5.1 Summary of heritability of dependence on selected substances

                   Substance    Heritability  Linkage           Candidate genes
                                 estimates
                                (%)
                   Nicotine     60–80    Chromosome 5q near D1  CYP2A6
                                         receptor loci          Dopamine D4 receptor
                                                                Dopamine Beta hydroxylase
                   Alcohol      52–63    Loci on chromosomes 4q,  ALDH2
                                         6, 1, 7, 2, 11p, 10q   ADH
                                                                CYP2E1
                                                                GABA  α6, β1, β3, γ2
                                                                    A
                                                                Dopamine D4 receptor
                                                                COMT (catechol-O
                                                                methyltransferase)
                                                                Serotonin 2A receptor
                   Opioids      70       None identified        CYP2D6
                   Combined risk for 50–80  Loci on chromosome 15,  Dopamine D1 receptor
                   substance             19q12-13               Dopamine D2 receptor
                   dependence                                   Dopamine D4 receptor
                   in general                                   Monoamine oxidase A




                   References
                   Agarwal DP (2001) Genetic polymorphisms of alcohol metabolizing enzymes.
                   Pathology and Biology (Paris), 49:703–709.
                   Albanese V et al. (2001) Quantitative effects on gene silencing by allelic variation
                   at a tetranucleotide microsatellite. Human Molecular Genetics, 10:1785–1792.


                                                  152




          Chapter_5                152                             19.1.2004, 11:46
   168   169   170   171   172   173   174   175   176   177   178